M. Boutin

Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.

S. Zweegman, J. Krok-Schoen, T. Wildes, 2020, Journal of geriatric oncology.

Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?

J. Loree, M. Boutin, João Paulo Solar Vasconcelos, 2022, Therapeutic advances in medical oncology.

Well-Differentiated Grade 3 Neuroendocrine Tumors

S. Gill, D. Farnell, J. Loree, 2022, Pancreas.

Controversies and management of deficient mismatch repair gastrointestinal cancers in the neoadjuvant setting

S. Gill, M. Boutin, 2023, Therapeutic advances in medical oncology.

Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer

H. Feilotter, D. Tu, H. Kennecke, 2023, Therapeutic advances in medical oncology.

[Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].

É. Bonneil, J. Bijl, S. Bourassa, 2017 .

Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification

É. Bonneil, J. Bijl, S. Bourassa, 2017, Molecular Biology.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Marcelo A. Falappa, Tariq M. Alhawassi, A. Laupacis, 2021, BMJ.

Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification

É. Bonneil, J. Bijl, S. Bourassa, 2017, Molecular Biology.